Cetuximab sensitivity of head and neck squamous cell carcinoma xenografts is associated with treatment‐induced reduction in EGFR, pEGFR, and pSrc
Adam Jedlinski; Stina Garvin; Ann‐Charlotte Johansson; Per‐Henrik Edqvist; Fredrik Ponten; Karin Roberg
Author Information: Department of ENT ‐ Head and Neck Surgery
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.